top of page
Portfolio: Portfolio
Office Building


New Rhein Funds II and III have invested in seven companies developing proprietary drug/device platforms for the treatment of COPD, BPH, COVID-19, migraine etc.


Past Deals

Prior investments have included medicines for Alzheimer’s disease, ophthalmic disorders, respiratory disease, and molecular oncology diagnostics.  

bottom of page